LINK Medical Research

New cell therapy raises hope for curing type 1 diabetes – "Never succeeded before"

For the first time, a patient with type 1 diabetes has undergone an islet transplantation using genetically modified insulin-producing cells that do not require...

Higher throughput in less time

Do you want to automate your quality processes, shorten inspection times and increase your throughput? Gain inspiration from the experience of the medical technology manufacturer Orchid Orthopedic Solutions....

A new giant among our microscopes

Two technologies in one machine.

From lab to patient – the art of developing new antibody therapies

For 25 years, Danish company Genmab has been developing antibodies and has managed to get several drugs all the way to the patient. Esther Breij has been along ...

Investment CEO: “The Nordics are outstanding in creating successful medtech companies”

Since the beginning of last month, Susanna Francke Rodau has been a partner and the new CEO of Segulah Medical Acceleration, which invests in medical technology. In an interview she tells about which companies the investment company prefers to invest...

Brådska på myndigheter inför nya EU-regler

Korta tidsramar och begränsade resurser. Det är några av utmaningarna som identifierats när tre myndigheter har utrett hur HTA-förordningen kan införas effektivt i Sverige.

No longer afraid of the dentist.

Teaching robot with piezo technology

Bredd och spets på välbesökt life science-event

Hela kedjan inom läkemedelsframställning – från den tidiga forskningen till fyllning av vialer – var representerad när konferensen New Horizons in Biologics & B...

Nytt namn till Pixelgens vetenskapliga råd

Pixelgen har tillsatt Mostafa Ronaghi till sitt vetenskapliga råd.

Elevating 3D characterization with enhanced performance and efficiencies

Introducing the ZEISS VersaXRM 730 3D X-ray microscope.

Explore the latest trends and innovations in quality assurance and manufacturing

ZEISS QUALITY INNOVATION SUMMIT in Berlin, October 22-24, 2024.

From powder to implant

Quality assurance for additively manufactured implants.

Fast Optical Sectioning of Developing Organisms and Tissue Microstructures

ZEISS Lattice SIM 3 exploits the full potential of the SIM Apotome technology.

Improved processes and more

Discover the full potential and benefits.

Roche’s Genentech terminates licencing deal with Norwegian biotech

Genentech is ending a license collaboration with Norwegian biotech Nykode Therapeutics regarding a clinical stage cancer vaccine program.

Sobi announces agreement with Enable Injections

Swedish biopharma Sobi has entered into an international development and distribution agreement with US drug delivery company Enable Injections.

The new Swedish life science strategy – “It will consolidate Sweden as a leader”

Clinical trials and precision health are emphasised as key areas in the new national life science strategy.

Rekordmånga biotech-konkurser i USA

Fjolåret var tufft för många företag inom biotech. I USA var antalet konkurser i branschen det högsta sedan 2010, visar en sammanställning.

Ny vd för Voc Diagnostics

Voc Diagnostics internrekryterar. Lotta Tollstoy Tegler som idag är ansvarig för kvalitets- och regulatoriska frågor är bolagets nya vd.

Halvårsbokslut från ZEISS med tvåsiffrig tillväxt

Trots en utmanande marknad lyckades ZEISS-koncernen under perioden 1 oktober 2023–31 mars 2024 nå en omsättning på 5,3 miljarder euro.

Save the dates: ZEISS Quality Innovation Summit, October 22-24

Embark on a journey to the future of metrology.

Setback for Moderna in patent dispute with mRNA competitors

Moderna has suffered a setback in a patent battle against their worst competitors in covid vaccines, Biontech and its partner Pfizer.

SupraCube - In life Science

Superconductors must be permanently kept below their transition temperature for levitation. Because of the integrated cooler, applications with superconductors ...